FDA grants Theradaptive Breakthrough Medical Device designation
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
This strategic collaboration will enable continued innovation in cancer care
Equity raise to finance growth and investments in the biological space
The transaction is anticipated to close in the first quarter of 2022
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
        Subscribe To Our Newsletter & Stay Updated